Aviva PLC Kodiak Sciences Inc. Transaction History

Aviva PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $2.66 Million - $3.96 Million	-24,101 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$60.78 - $154.03 $1.19 Million - $3.01 Million	-19,536 Reduced 44.77%	24,101 $3.54 Million
Q3 2020 Nov 12, 2020	BUY	$45.05 - $59.27 $1.97 Million - $2.59 Million	43,637 New	43,637 $2.58 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $303M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.